Home › Myelodysplastic Syndromes › District of Columbia › Washington
Pag-aaral pangklinika para sa Myelodysplastic Syndromes sa Washington, DC
Isang pag-aaral para sa Myelodysplastic Syndromes ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Washington. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Nagre-recruitPhase 2
- Walter Reed National Military Medical Center, Bethesda · 7 mi ang layo
Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)
Nagre-recruitPhase 2
- Walter Reed National Military Medical Center, Bethesda · 7 mi ang layo
Natural History of Trisomy 8-Associated Autoinflammatory Disease (TRIAD) and Related Disorders
Nagre-recruitObservasyonal na pag-aaral
- National Institutes of Health Clinical Center, Bethesda · 7 mi ang layo
Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies
Nagre-recruitPhase 1
- National Institutes of Health Clinical Center, Bethesda · 7 mi ang layo
Pacritinib, a Kinase Inhibitor of CSF1R, IRAK1, JAK2, and FLT3, in Adults and Pediatric Participants 12 Years of Age or Older With Myelodysplastic Syndromes or Myelodysplastic/Myeloproliferative Neoplasms
Nagre-recruitPhase 1/2
- National Institutes of Health Clinical Center, Bethesda · 7 mi ang layo
Unrelated Umbilical Cord Blood Transplantation for Severe Aplastic Anemia and Hypo-plastic MDS Using CordIn(TM), Umbilical Cord Blood-Derived Ex Vivo Expanded Stem and Progenitor Cells to Expedite Engraftment and Improve Transplant Outcome
Nagre-recruitPhase 1/2
- National Institutes of Health Clinical Center, Bethesda · 7 mi ang layo
CHIP/CCUS Natural History Protocol
Nagre-recruitObservasyonal na pag-aaral
- National Institutes of Health Clinical Center, Bethesda · 7 mi ang layo
Natural History Study of GATA2 Deficiency and Related Disorders
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
- National Institutes of Health Clinical Center, Bethesda · 7 mi ang layo
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
Nagre-recruitPhase 2
- National Institutes of Health Clinical Center, Bethesda · 7 mi ang layo
Collection of Tissue Samples for Cancer Research
Nagre-recruitObservasyonal na pag-aaral
- National Institutes of Health Clinical Center, Bethesda · 7 mi ang layo
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Nagre-recruitPhase 1/2
- Children's National Medical Center, Washington D.C.
A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS)
Nagre-recruitPhase 2
- The Center for Cancer and Blood Disorders (CCBD) - Bethesda, Bethesda · 7 mi ang layo
Mosaic Trial for Stem Cell Transplant Recipients
Nagre-recruit
- Georgetown University School of Medicine, Washington D.C.
Comprehensive Molecular and Clinical Evaluation of Pediatric and Adult MDS
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
- National Institutes of Health Clinical Center, Bethesda · 7 mi ang layo
Collection of Blood, Bone Marrow, Skin, Saliva, and Stool Samples From Healthy Volunteers Used for Comparative Analysis of Myeloid Malignancies
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
- National Institutes of Health Clinical Center, Bethesda · 7 mi ang layo
A Phase II Study of Allogeneic Hematopoietic Stem Cell Transplant for Subjects With VEXAS (Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic) Syndrome
Nagre-recruitPhase 2
- National Institutes of Health Clinical Center, Bethesda · 7 mi ang layo
Study of Individuals and Families With Aberrations in DDX41 or Similar Cancer Predisposition Variants
Nagre-recruitObservasyonal na pag-aaral
- National Institutes of Health Clinical Center, Bethesda · 7 mi ang layo
Cancer Experience Registry (CER) for Cancer Patients and Caregivers
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
- Cancer Support Community Research & Training Institute, Washington D.C.
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
Nagre-recruitPhase 1/2
- Georgetown Lombardi Comprehensive Cancer Center, Washington D.C.
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Nagre-recruitObservasyonal na pag-aaral
- Massive Bio SYNERGY-AI site, Silver Spring · 7 mi ang layo
- Massive Bio SYNERGY-AI site, Bethesda · 7 mi ang layo
Pag-aaral para sa Myelodysplastic Syndromes sa ibang lungsod
- Houston, TX43 pag-aaral
- Baldwin Park, CA26 pag-aaral
- New York City, NY21 pag-aaral
- Seattle, WA21 pag-aaral
- Tampa, FL19 pag-aaral
- Boston, MA19 pag-aaral
- Miami, FL17 pag-aaral
- Durham, NC14 pag-aaral
- Columbus, OH14 pag-aaral
- St. Louis, MO13 pag-aaral
- Atlanta, GA13 pag-aaral
- Chicago, IL13 pag-aaral
Iba pang pag-aaral sa Washington
- Kanser (lahat ng uri)58 pag-aaral
- Non-Small Cell Lung Cancer55 pag-aaral
- Kanser sa Suso46 pag-aaral
- Metastatic Cancer43 pag-aaral
- Kanser sa Baga41 pag-aaral
- Kanser sa Prostate38 pag-aaral
- Obesity33 pag-aaral
- Colorectal Cancer29 pag-aaral
- Sakit sa Puso at Ugat ng Dugo28 pag-aaral
- Kanser sa Pantog26 pag-aaral
- Acute Myeloid Leukemia24 pag-aaral
- Kanser sa Ovary23 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.